OP16 A novel artificial intelligence-assisted Image Enhanced Endoscopy assesses accurately “vascular-healing” and predicts long-term clinical relapse in patients with ulcerative colitis: a prospective cohort study

Y Maeda,S E Kudo,T Kuroki,M Masashi,N Ogata,H Miyachi,T Baba,T Nemoto,K Ohtsuka,M Iacucci
DOI: https://doi.org/10.1093/ecco-jcc/jjad212.0016
2024-01-01
Journal of Crohn's and Colitis
Abstract:Abstract Background Ulcerative colitis (UC) is a chronic specific inflammatory bowel disease that alternates between remission and relapse statuses. Microvascular finding observed in image-enhanced endoscopy (IEE) has been attracting attention to detect inflammation and predict outcomes in patients with UC; however, this requires specialist endoscopists. Artificial intelligence (AI)-assisted IEE may help to overcome this problem. We developed a novel AI-based narrow-band imaging (NBI) system, using 8853 images from 167 patients, that can be adapted to commercially available various endoscopes and determined if AI-identified ‘vascular-healing’ could predict relapse and guide treatment in patients with UC. Methods This prospective cohort study analyzed data from 100 patients with UC in clinical remission. The endoscopists performed colonoscopy using the AI system, which outputs identified the target mucosa as vascular-active or vascular-healing. The Mayo endoscopic subscore (MES), AI outputs, and histological assessment were recorded for six colorectal segments of each patient. Patients were then followed up for 12 months. Clinical relapse was defined as a partial Mayo score >2. Results The clinical relapse rate was significantly higher in the AI-based vascular-active group [23.9% (16/67)] compared with the AI-based vascular-healing group [3.0% (1/33)] (P=0.01). In a sub-analysis predicting clinical relapse in patients with MES ≤1, the area under the curve for the combination of complete endoscopic remission and vascular healing (0.70) was increased compared with that for complete endoscopic remission (MES=0) alone (0.65). Colonoscopy by a total of 27 endoscopists, comprising 11 experts and 16 trainees, evaluated 35 and 65 patients, respectively. The sensitivity, specificity, and accuracy for predicting clinical relapse did not differ significantly according to the endoscopist’s experience: 100%, 39.3%, and 51.4%, respectively, for experts and 90.0%, 38.2%, and 46.2%, respectively, for trainees (P>0.95, P>0.95, and P=0.84, respectively). Conclusion Colonoscopy using the AI-based NBI system for diagnosing “vascular-healing” identifies patients with UC at high risk of relapse and thus aids future disease management.
gastroenterology & hepatology
What problem does this paper attempt to address?